FIELD: medicine, clinical immunology.
SUBSTANCE: method involves determination of activity the complex mannan-binding lectin with associated serine proteases in patients by measurement of serum blood complement consumption before and after incubation in buffer solution with addition of ethylenediaminotetraacetic acid in vitro wherein this acid is neutralized with a titrated solution with Ca2+ and Mg2+, the following addition of ram erythrocytes sensitized with rabbit antibodies followed by repeated incubation. The complement consumption indices are determined by erythrocytes lysis degree: index below 30% is estimated as the reduced response of the human immune system; index from 30% to 70% is estimated as the normal response, and index above 70% is estimated as the enhanced response. Using the proposed simple and rapid method provides detection of preclinical state of immune deficiency, to carry out the deepened study of autoimmune diseases pathogenesis, their early prophylaxis and to control the effectiveness of therapy carried out.
EFFECT: improved method for estimation.
3 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ASSAY OF IMMUNE STATUS DISORDER | 2002 |
|
RU2247381C2 |
METHOD FOR DETERMINING THE INHIBITORY POTENTIAL OF BLOOD FOR PREDICTING UNCONTROLLED ACTIVATION OF COMPLEMENT SYSTEM IN COVID-19 | 2023 |
|
RU2814496C1 |
SCREENING TEST FOR DETERMINING THE FUNCTIONAL ACTIVITY OF THE CLASSIC COMPLEMENT PATHWAY | 2018 |
|
RU2704121C1 |
METHOD FOR DETERMINATION FUNCTIONAL ACTIVITY OF C3-CONVERTASE OF ALTERNATIVE PATH OF HUMAN COMPLEMENT ACTIVATION | 2017 |
|
RU2666957C1 |
METHOD FOR DETERMINING ACTIVITY OF MANNAN-BINDING LECTIN-ASSOCIATED SERINE PROTEASES IN A FIBRINOGEN COAGULATION TEST | 2019 |
|
RU2739113C1 |
DETERMINING THE ACTIVITY OF THE CLASSICAL PATHWAY OF THE COMPLEMENT SYSTEM IN A FIBRINOGEN COAGULATION TEST | 2019 |
|
RU2707568C1 |
SCREENING TEST FOR DETERMINATION OF THE FUNCTIONAL ACTIVITY OF THE RAT COMPLEMENT SYSTEM | 2022 |
|
RU2786208C1 |
METHOD OF DETERMINING THE ACTIVITY OF THE CLASSICAL AND ALTERNATIVE PATHWAYS OF THE MOUSE COMPLEMENT SYSTEM | 2022 |
|
RU2800363C1 |
METHOD FOR DETERMINING COMPLEMENT-ACTIVATING FUNCTION OF SARS-CoV-2 ANTIBODIES FOR PREDICTING SEVERITY OF COVID-19 | 2023 |
|
RU2818351C1 |
METHOD OF PREDICTING SEVERITY OF SYSTEMIC INFLAMMATORY RESPONSE IN HUMAN BODY IN DISEASES | 2022 |
|
RU2808416C1 |
Authors
Dates
2008-01-10—Published
2006-05-18—Filed